News

Novo Nordisk will sell a less expensive one-month supply of Wegovy for patients who previously took compounded versions of ...
Researchers are beginning to wonder if blockbuster drugs like Wegovy, Ozempic and Zepbound could play a role in preventing ...
Novo Nordisk A/S is selling its blockbuster weight-loss drug Wegovy to new patients at $199 for the first month as easy ...
Inadequate supply has created opportunities for bad actors seeking to profit from shortages, high costs and demand ...
The Danish drugmaker Novo Nordisk announced it has temporarily reduced the price of the weight-loss drug Wegovy for new customers as it attempts to limit sales of compounded versions of the medication ...
Investing.com -- Cigna’s Evernorth has introduced a new pharmacy benefit that caps out-of-pocket costs for GLP-1 weight loss ...
Wegovy belongs to a pricey class of drugs called GLP-1s (short for glucagon-like peptide-1 agonists) that have upended the ...
Health plan sponsors are also expected to see a reduction in the net cost per prescription of GLP-1 medications to treat obesity.
Novo Nordisk reduced its starter dose prices through telehealth platforms to encourage patients to wean themselves off compounded copycats.
The growing use of weight loss drugs like Ozempic raises concerns over ‘Ozempic teeth,’ linked to dry mouth and dental issues ...
U.S. prices for new drugs more than doubled last year compared to 2021, as companies developed more therapies for rare ...